18 results on '"Kulikowski M"'
Search Results
2. The prognostic significance of the immunohistochemical expression of P53 and BCL-2 in endometrial cancer
- Author
-
Kulikowski M, Magdalena Garbowicz, Slawomir J. Terlikowski, Lech Chyczewski, Jacek Niklinski, and Bozena Dobrzycka
- Subjects
Oncology ,medicine.medical_specialty ,Histology ,BCL-2 ,Kaplan-Meier Estimate ,Pathology and Forensic Medicine ,Internal medicine ,medicine ,Carcinoma ,Humans ,lcsh:QH573-671 ,Stage (cooking) ,P53 expression ,Lymph node ,Aged ,P53 ,lcsh:Cytology ,business.industry ,Endometrial cancer ,Cancer ,General Medicine ,Middle Aged ,medicine.disease ,Immunohistochemistry ,Endometrial Neoplasms ,medicine.anatomical_structure ,Proto-Oncogene Proteins c-bcl-2 ,endometrial cancer ,Biomarker (medicine) ,Female ,prognosis ,Tumor Suppressor Protein p53 ,business - Abstract
The objective of this study was to verify the frequency of P53 and BCL-2 immunohistochemical expression in 98 patients with endometrial carcinoma, and to correlate it with clinical stage and patient survival. A significant difference was found regarding the frequency of P53 expression when comparing type I and II tumors (23.7% and 54.5%, respectively; p = 0.006). A positive correlation was observed between P53 immunoexpression and patient survival in type I and II tumors (p = 0.009 and p = 0.036, respectively). BCL-2 expression was significantly more frequent in early clinical stages in both types of endometrial cancer (p < 0.001 and 0.002) and correlated with a decrease in overall survival in type I endometrial cancer (p = 0.014). Thus, the prognostic value of these biomarkers in endometrial cancer needs to be further investigated. (Folia Histochemica et Cytobiologica 2011; Vol. 49, No. 4, pp. 631–635)
- Published
- 2012
3. Prognostic significance of smac/DIABLO in endometrioid endometrial cancer
- Author
-
Magdalena Garbowicz, Kulikowski M, Bozena Dobrzycka, Lech Chyczewski, Jacek Niklinski, Piotr Bernaczyk, and Slawomir J. Terlikowski
- Subjects
Cell physiology ,Programmed cell death ,Pathology ,medicine.medical_specialty ,Histology ,endometrioid endometrial cancer ,Apoptosis ,Pathology and Forensic Medicine ,Mitochondrial Proteins ,Western blot ,medicine ,Humans ,smac/DIABLO ,lcsh:QH573-671 ,Inner mitochondrial membrane ,Caspase ,Aged ,biology ,medicine.diagnostic_test ,lcsh:Cytology ,Endometrial cancer ,Intracellular Signaling Peptides and Proteins ,General Medicine ,Middle Aged ,medicine.disease ,Immunohistochemistry ,Endometrial Neoplasms ,biology.protein ,Cancer research ,Female ,prognosis ,biological phenomena, cell phenomena, and immunity ,Apoptosis Regulatory Proteins - Abstract
Apoptosis may occur via a death receptor-dependent or independent (mitochondrial) pathway. The mitochondrial pathway is regulated by small molecules, such as smac/Diablo, which activates caspase cascades. This study examined smac/DIABLO expression in 76 patients with endometrioid endometrial cancers. Presence of smac/DIABLO was quantified by Western blot analysis using nonfixed fresh frozen tissues. Its appearance was found in 55 (72%) of examined tumors. Smac/DIABLO expression significantly correlated with tumor grade (p
- Published
- 2011
4. Marius Maximus in Ammianus and the Historia Augusta
- Author
-
Kulikowski, M.
- Subjects
Greek literature -- Analysis ,Gods, Greek -- Portrayals ,History ,Languages and linguistics ,Literature/writing ,Philosophy and religion ,Regional focus/area studies - Abstract
The comparison of Ammianus and the Historia Augusta is revealed in the Vita Hadriani drawn on Maximus. It is suggested that Ammianus' consulted Maximus, his hostile view of Hadrian is very evident and Maximus is the source for Vita Hadriani.
- Published
- 2007
5. Effect of hepatitis B virus (HBV) infection on the course of pregnancy and newborns' health status
- Author
-
Krzysztof Tomasiewicz, Dariusz Marek Lebensztejn, Tadeusz Wojciech Łapiński, Robert Flisiak, Kulikowski M, and Julita Stepaniuk
- Subjects
Hepatitis B virus ,medicine.medical_specialty ,education.field_of_study ,Pregnancy ,newborns ,Hepatology ,business.industry ,Obstetrics ,Population ,virus diseases ,medicine.disease ,medicine.disease_cause ,Virus ,digestive system diseases ,Miscarriage ,HBeAg ,Medicine ,Apgar score ,Original Article ,pregnancy ,business ,education ,Viral load ,HBV infection - Abstract
Introduction The effect of chronic hepatitis B virus (HBV) infection on pregnancy is not clear. Hepatitis B virus infection of newborns in the case of natural delivery occurs in 70-90% of cases. Risk factors of infection are the presence of serum HBeAg and HBV DNA level above 107 IU/ml. Active and passive prevention protect more than 95% of neonates born to mothers infected with HBV. The aim of the study was to determine the course of pregnancy in HBV-infected women, the mode of delivery, efficacy of prophylaxis against HBV infection in newborns, and health condition of newborns within the first years of life. Material and methods The course of 104 pregnancies in 69 women infected with HBV was monitored. Hepatitis B virus viral load was determined by PCR using the AmpliPre/COBAS TaqMan HBV system. Neonatal HBV infection and the health condition at birth and during the first year of life were analyzed. Results All included pregnant women were HBeAg negative. No clinically significant disorders were observed during pregnancy. Viral load measured in the third trimester did not exceed 107 IU/ml in any pregnant woman. Only 5 (8%) of them demonstrated levels above 105 IU/ml. Two women (1.9%) experienced a miscarriage, which was considered as not associated with HBV infection. The majority (56%) of pregnancies ended with spontaneous labor. Complete prevention against HBV was applied in 79% of newborns. Hepatitis B virus infection was diagnosed in 3 children who received incomplete or no prophylaxis. Hepatitis B virus infection occurred in 3 (2.9%) children born naturally, who did not receive proper prevention after delivery. The Apgar score in children born to mothers infected with HBV did not differ significantly from that in neonates born to healthy women from the same population. Allergic disorders developed in 17 children who underwent HBV prophylaxis. Conclusions Low viral load in pregnant women infected with HBV and the absence of HBeAg reduce the probability of infection of newborns. Proper prevention carried out after delivery seems to be the most important method to prevent HBV infection in newborns.
- Published
- 2015
6. Mutations in the KRAS gene in ovarian tumors
- Author
-
Kulikowski M, Wieslawa Niklinska, Slawomir J. Terlikowski, Bozena Dobrzycka, Oksana Kowalczuk, and Lech Chyczewski
- Subjects
Adult ,Oncology ,medicine.medical_specialty ,Histology ,endocrine system diseases ,Gene mutation ,medicine.disease_cause ,Pathology and Forensic Medicine ,Proto-Oncogene Proteins p21(ras) ,Ovarian tumor ,Proto-Oncogene Proteins ,Internal medicine ,Humans ,Medicine ,lcsh:QH573-671 ,Mutation frequency ,Aged ,Ovarian Neoplasms ,Mutation ,Reverse Transcriptase Polymerase Chain Reaction ,lcsh:Cytology ,business.industry ,General Medicine ,Middle Aged ,medicine.disease ,Serous fluid ,ras Proteins ,Cancer research ,Immunohistochemistry ,Female ,KRAS ,business ,Ovarian cancer - Abstract
RAS genes are the most frequently mutated oncogenes detected in human cancer. In this study we analyzed the presence of mutations at codon 12 of the KRAS gene in 78 women with ovarian tumor, including 64 invasive ovarian cancers and 14 borderline ovarian tumors, using an RFLP-PCR technique and we evaluated whether such alterations were associated with the selected clinicopathological parameters of the patients. KRAS codon 12 gene mutations were found in 6,2% of ovarian cancer tissue and in 14,3% of the borderline ovarian tumor. KRAS mutations were found with a significantly higher frequency in mucinous and borderline tumors compared to serous tumors (p
- Published
- 2009
7. Circulating free DNA, p53 antibody and mutations of KRAS gene in endometrial cancer
- Author
-
Kulikowski M, Bozena Dobrzycka, A Mazurek, Slawomir J. Terlikowski, Wieslawa Niklinska, Oksana Kowalczuk, and Lech Chyczewski
- Subjects
Cancer Research ,Pathology ,medicine.medical_specialty ,Tumor suppressor gene ,Enzyme-Linked Immunosorbent Assay ,Biology ,medicine.disease_cause ,Polymerase Chain Reaction ,Antibodies ,Polymorphism (computer science) ,medicine ,Humans ,Point Mutation ,Aged ,DNA Primers ,Base Sequence ,Endometrial cancer ,Point mutation ,Cancer ,DNA ,Middle Aged ,medicine.disease ,Endometrial Neoplasms ,Genes, ras ,Oncology ,Cancer research ,biology.protein ,Immunohistochemistry ,Female ,KRAS ,Antibody ,Tumor Suppressor Protein p53 ,Polymorphism, Restriction Fragment Length - Abstract
This study was conducted to evaluate the significance of circulating free DNA (CFDNA), p53 antibody (p53-Ab) and mutations of KRAS gene in the development of endometrial cancer (EC). A total of 109 patients with EC (87 patients with Type I and 22 patients with Type II) took part in this study. KRAS mutations and CFDNA were detected by means of the PCR-RFLP and enriched by the PCR-RFPL method. ELISA was used to analyze plasma p53-Ab. Tissue expression of P53 protein was evaluated immunohistochemically (IHC). The frequency of KRAS mutations was especially high in Grade 2 of Type I EC. CFDNA was frequently detected in patients with early stage of Type II EC at a low level of grade. It is noteworthy that the p53-Ab positive rate increased in the higher grade of Type I tumors. A significant difference in the number of cases with the p53-Ab was found in the advanced stage of Type I tumors. The frequency of KRAS and p53-Ab correlates with tumor stage only in the Type I EC. Plasma CFDNA and p53-Ab offer a chance to develop a procedure for EC Type II diagnosis. The association between tumor cells related to CFDNA and p53-Ab with Type II tumor suggests that it might potentially serve as a marker in predicting the prognosis and offers a possibility to individualize treatment regimen.
- Published
- 2009
8. Mutations of the KRAS oncogene in endometrial hyperplasia and carcinoma
- Author
-
Kulikowski M, A Mazurek, Oksana Kowalczuk, Wieslawa Niklinska, Lech Chyczewski, Slawomir J. Terlikowski, and Bozena Dobrzycka
- Subjects
Oncology ,medicine.medical_specialty ,Histology ,DNA Mutational Analysis ,Molecular Sequence Data ,Biology ,medicine.disease_cause ,Atypical hyperplasia ,Pathology and Forensic Medicine ,Proto-Oncogene Proteins p21(ras) ,KRAS Gene Mutation ,Internal medicine ,Proto-Oncogene Proteins ,medicine ,Carcinoma ,Humans ,lcsh:QH573-671 ,neoplasms ,Mutation ,Oncogene ,Base Sequence ,lcsh:Cytology ,Point mutation ,General Medicine ,Oncogenes ,Middle Aged ,medicine.disease ,digestive system diseases ,Endometrial hyperplasia ,Endometrial Neoplasms ,Endometrial Hyperplasia ,Cancer research ,ras Proteins ,Female ,KRAS - Abstract
The aim of this study was to examine the prevalence and clinicopathological significance of KRAS point mutation in endometrial hyperplasia and carcinoma. We analysed KRAS in 11 cases of complex atypical hyperplasia and in 49 endometrial carcinomas using polymerase chain reaction associated with restriction fragment length polymorphism (PCR-RFPL). Point mutations at codon 12 of KRAS oncogene were identified in 7 of 49 (14,3%) tumor specimens and in 2 of 11 (18,2%) hyperplasias. No correlation was found between KRAS gene mutation and age at onset, histology, grade of differentiation and clinical stage. We conclude that KRAS mutation is a relatively common event in endometrial carcinogenesis, but with no prognostic value.
- Published
- 2009
9. Orthodoxy and the Courts in Late Antiquity
- Author
-
Kulikowski, M., primary
- Published
- 2009
- Full Text
- View/download PDF
10. Visigothic Spain, 409-711
- Author
-
Kulikowski, M., primary
- Published
- 2008
- Full Text
- View/download PDF
11. Characterisation of the Viral Community Associated with the Alfalfa Weevil ( Hypera postica ) and Its Host Plant, Alfalfa ( Medicago sativa ).
- Author
-
François S, Antoine-Lorquin A, Kulikowski M, Frayssinet M, Filloux D, Fernandez E, Roumagnac P, Froissart R, and Ogliastro M
- Subjects
- Agriculture, Animals, Biodiversity, Ecosystem, Metagenome, Metagenomics methods, Phylogeny, Plant Diseases virology, Medicago sativa parasitology, Medicago sativa virology, Virome, Weevils virology
- Abstract
Advances in viral metagenomics have paved the way of virus discovery by making the exploration of viruses in any ecosystem possible. Applied to agroecosystems, such an approach opens new possibilities to explore how viruses circulate between insects and plants, which may help to optimise their management. It could also lead to identifying novel entomopathogenic viral resources potentially suitable for biocontrol strategies. We sampled the larvae of a natural population of alfalfa weevils ( Hypera postica ), a major herbivorous pest feeding on legumes, and its host plant alfalfa ( Medicago sativa ). Insect and plant samples were collected from a crop field and an adjacent meadow. We characterised the diversity and abundance of viruses associated with weevils and alfalfa, and described nine putative new virus species, including four associated with alfalfa and five with weevils. In addition, we found that trophic accumulation may result in a higher diversity of plant viruses in phytophagous pests compared to host plants.
- Published
- 2021
- Full Text
- View/download PDF
12. Effect of hepatitis B virus (HBV) infection on the course of pregnancy and newborns' health status.
- Author
-
Łapiński TW, Stepaniuk J, Tomasiewicz K, Lebensztejn D, Kulikowski M, and Flisiak R
- Abstract
Introduction: The effect of chronic hepatitis B virus (HBV) infection on pregnancy is not clear. Hepatitis B virus infection of newborns in the case of natural delivery occurs in 70-90% of cases. Risk factors of infection are the presence of serum HBeAg and HBV DNA level above 10
7 IU/ml. Active and passive prevention protect more than 95% of neonates born to mothers infected with HBV. The aim of the study was to determine the course of pregnancy in HBV-infected women, the mode of delivery, efficacy of prophylaxis against HBV infection in newborns, and health condition of newborns within the first years of life., Material and Methods: The course of 104 pregnancies in 69 women infected with HBV was monitored. Hepatitis B virus viral load was determined by PCR using the AmpliPre/COBAS TaqMan HBV system. Neonatal HBV infection and the health condition at birth and during the first year of life were analyzed., Results: All included pregnant women were HBeAg negative. No clinically significant disorders were observed during pregnancy. Viral load measured in the third trimester did not exceed 107 IU/ml in any pregnant woman. Only 5 (8%) of them demonstrated levels above 105 IU/ml. Two women (1.9%) experienced a miscarriage, which was considered as not associated with HBV infection. The majority (56%) of pregnancies ended with spontaneous labor. Complete prevention against HBV was applied in 79% of newborns. Hepatitis B virus infection was diagnosed in 3 children who received incomplete or no prophylaxis. Hepatitis B virus infection occurred in 3 (2.9%) children born naturally, who did not receive proper prevention after delivery. The Apgar score in children born to mothers infected with HBV did not differ significantly from that in neonates born to healthy women from the same population. Allergic disorders developed in 17 children who underwent HBV prophylaxis., Conclusions: Low viral load in pregnant women infected with HBV and the absence of HBeAg reduce the probability of infection of newborns. Proper prevention carried out after delivery seems to be the most important method to prevent HBV infection in newborns.- Published
- 2015
- Full Text
- View/download PDF
13. The prognostic significance of the immunohistochemical expression of P53 and BCL-2 in endometrial cancer.
- Author
-
Dobrzycka B, Terlikowski SJ, Garbowicz M, Niklinski J, Chyczewski L, and Kulikowski M
- Subjects
- Aged, Endometrial Neoplasms pathology, Female, Humans, Immunohistochemistry, Kaplan-Meier Estimate, Middle Aged, Endometrial Neoplasms metabolism, Proto-Oncogene Proteins c-bcl-2 metabolism, Tumor Suppressor Protein p53 metabolism
- Abstract
The objective of this study was to verify the frequency of P53 and BCL-2 immunohistochemical expression in 98 patients with endometrial carcinoma, and to correlate it with clinical stage and patient survival. A significant difference was found regarding the frequency of P53 expression when comparing type I and II tumors (23.7% and 54.5%, respectively; p = 0.006). A positive correlation was observed between P53 immunoexpression and patient survival in type I and II tumors (p = 0.009 and p = 0.036, respectively). BCL-2 expression was significantly more frequent in early clinical stages in both types of endometrial cancer (p 〈 0.001 and 0.002) and correlated with a decrease in overall survival in type I endometrial cancer (p = 0.014). Thus, the prognostic value of these biomarkers in endometrial cancer needs to be further investigated.
- Published
- 2011
- Full Text
- View/download PDF
14. Prognostic significance of smac/DIABLO in endometrioid endometrial cancer.
- Author
-
Dobrzycka B, Terlikowski SJ, Bernaczyk PS, Garbowicz M, Niklinski J, Chyczewski L, and Kulikowski M
- Subjects
- Aged, Apoptosis, Apoptosis Regulatory Proteins, Endometrial Neoplasms diagnosis, Endometrial Neoplasms pathology, Female, Humans, Immunohistochemistry, Middle Aged, Prognosis, Endometrial Neoplasms mortality, Intracellular Signaling Peptides and Proteins metabolism, Mitochondrial Proteins metabolism
- Abstract
Apoptosis may occur via a death receptor-dependent or independent (mitochondrial) pathway. The mitochondrial pathway is regulated by small molecules, such as smac/Diablo, which activates caspase cascades. This study examined smac/DIABLO expression in 76 patients with endometrioid endometrial cancers. Presence of smac/DIABLO was quantified by Western blot analysis using nonfixed fresh frozen tissues. Its appearance was found in 55 (72%) of examined tumors. Smac/DIABLO expression significantly correlated with tumor grade (p<0.001). Patients with positive smac/DIABLO tumors had a longer disease-specific survival when compared with those with negative tumors in the 10-year follow-up (p=0.043). The study demonstrated that negative smac/DIABLO expression was a poor prognostic sign.
- Published
- 2010
- Full Text
- View/download PDF
15. Mutations of the KRAS oncogene in endometrial hyperplasia and carcinoma.
- Author
-
Dobrzycka B, Terlikowski SJ, Mazurek A, Kowalczuk O, Niklińska W, Chyczewski L, and Kulikowski M
- Subjects
- Base Sequence, DNA Mutational Analysis, Endometrial Hyperplasia pathology, Endometrial Neoplasms pathology, Female, Humans, Middle Aged, Molecular Sequence Data, Proto-Oncogene Proteins p21(ras), Endometrial Hyperplasia genetics, Endometrial Neoplasms genetics, Mutation genetics, Oncogenes genetics, Proto-Oncogene Proteins genetics, ras Proteins genetics
- Abstract
The aim of this study was to examine the prevalence and clinicopathological significance of KRAS point mutation in endometrial hyperplasia and carcinoma. We analysed KRAS in 11 cases of complex atypical hyperplasia and in 49 endometrial carcinomas using polymerase chain reaction associated with restriction fragment length polymorphism (PCR-RFPL). Point mutations at codon 12 of KRAS oncogene were identified in 7 of 49 (14,3%) tumor specimens and in 2 of 11 (18,2%) hyperplasias. No correlation was found between KRAS gene mutation and age at onset, histology, grade of differentiation and clinical stage. We conclude that KRAS mutation is a relatively common event in endometrial carcinogenesis, but with no prognostic value.
- Published
- 2009
- Full Text
- View/download PDF
16. Mutations in the KRAS gene in ovarian tumors.
- Author
-
Dobrzycka B, Terlikowski SJ, Kowalczuk O, Niklińska W, Chyczewski L, and Kulikowski M
- Subjects
- Adult, Aged, Female, Humans, Middle Aged, Mutation, Ovarian Neoplasms physiopathology, Proto-Oncogene Proteins p21(ras), Reverse Transcriptase Polymerase Chain Reaction, Ovarian Neoplasms genetics, Proto-Oncogene Proteins genetics, ras Proteins genetics
- Abstract
RAS genes are the most frequently mutated oncogenes detected in human cancer. In this study we analyzed the presence of mutations at codon 12 of the KRAS gene in 78 women with ovarian tumor, including 64 invasive ovarian cancers and 14 borderline ovarian tumors, using an RFLP-PCR technique and we evaluated whether such alterations were associated with the selected clinicopathological parameters of the patients. KRAS codon 12 gene mutations were found in 6,2% of ovarian cancer tissue and in 14,3% of the borderline ovarian tumor. KRAS mutations were found with a significantly higher frequency in mucinous and borderline tumors compared to serous tumors (p<0,01). Mutation frequency was correlated with the histological type of tumor, but not with stage, grade or patients age.
- Published
- 2009
- Full Text
- View/download PDF
17. [Polish Gynecological Society's recommendations regarding cesarean section].
- Author
-
Poreba R, Brazert J, Chazan B, Czajka R, Czajkowski K, Debski R, Drews K, Jaworski S, Karowicz-Bilińska A, Kubicki J, Laudański T, Makuch K, Kulikowski M, Malinowski W, Marianowski L, Niemiec T, Olejek A, Oleszczuk J, Oszukowski P, Radowicki S, Reroń A, Ronin-Walknowska E, Słomko Z, Szymański W, Wielgoś M, Wilczyński J, Zimmer M, Waszyński E, Jóźwik M, and Polish Gynecological Society
- Subjects
- Congresses as Topic, Female, Humans, Inservice Training standards, National Health Programs standards, Obstetric Labor Complications prevention & control, Poland, Pregnancy, Quality Assurance, Health Care standards, Societies, Medical standards, Women's Health Services organization & administration, Cesarean Section standards, Obstetric Labor Complications diagnosis, Obstetric Labor Complications surgery, Women's Health
- Published
- 2008
18. Familial occurrence of isodicentric X chromosomes with different breakpoints.
- Author
-
Midro AT, Kulikowski M, Sawicka A, Panasiuk B, and Korsak E
- Subjects
- Adult, Female, Humans, Karyotyping, Middle Aged, Pedigree, Turner Syndrome genetics, Sex Chromosome Aberrations genetics, X Chromosome
- Abstract
We report two cases of an idic (X) chromosome found in relatives with Turner's syndrome. A 21-year-old female revealed a non-mosaic form of X isochromosome of the long arms with two C-band regions, i.e. dic(X)(qter----cen----p11::p11----cen----qter). Her 46-year-old aunt with Turner's syndrome had an X chromosome with long arm breakpoints at site q21 and chromosomal mosaicism, i.e. 45,X/46,X, dic(X)(pter----q21::q21----pter)(78/22). The relative rarity of reports about familial Turner's syndrome with structural abnormality may suggest a coincidence. However, it is difficult to exclude familial predisposition to X isochromosome formation in this family.
- Published
- 1988
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.